Study on QOL improvement with the glucide diet which enhanced protein and EPA in advanced colorectal cancer and breast cancer for stage IV - Study of the glucide diet for the advanced cancer

Tama-Nanbu Regional Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation. Department of Surgery0 个研究点目标入组 20 人开始时间: 2017年10月15日最近更新: 2023年10月17日

适应症

试验速览

阶段: 1 期
状态: 已完成
发起方
入组人数: 20

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

A 3-month combination of the modified MCT ketogenic diet and chemotherapy was safe for stage IV cancer patients and allowed them to maintain quality of life. We believe that tumor reduction was associated with blood ketone body level.

研究设计

研究类型: Interventional

入排标准

年龄范围: 20years-old 至 75years-old（—）
性别: All

入选标准

未提供

排除标准

•Diabetic patient Cachexy patient

研究者

发起方

Tama-Nanbu Regional Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation. Department of Surgery

相似试验

已完成

1 期

Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast CancerStage IV Breast Cancer AJCC v6 and v7

NCT03535701Ohio State University Comprehensive Cancer Center20

Unknown

1 期

Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System LymphomaPrimary Central Nervous System Lymphoma

NCT02983942Beijing Tiantan Hospital50

终止

不适用

Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG)Carcinoma, Non-Small-Cell Lung

NCT01419587University of Iowa11

终止

不适用

Ketogenic Diet With Concurrent Chemoradiation for Pancreatic CancerPancreatic Neoplasms

NCT01419483University of Iowa5

终止

不适用

Ketogenic Diet Phase 1 for Head & Neck CancerHead and Neck Neoplasms

NCT01975766Bryan Allen14